Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Nov;21(6):483-484.
doi: 10.3988/jcn.2025.0527.

Beyond Single Biomarkers: Toward Integrated Staging in Alzheimer's Disease

Jae-Sung Lim  1
Affiliations
Editorial

Beyond Single Biomarkers: Toward Integrated Staging in Alzheimer's Disease

Jae-Sung Lim. J Clin Neurol. 2025 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author has no potential conflicts of interest to disclose.

References

    1. Lee YG, Kang SW, Lee S, Jeon S, Ye BS, Yun M, et al. Clinical implications of an integrated clinical and biological staging scheme for Alzheimer’s disease. J Clin Neurol. 2025;21:502–513. - PMC - PubMed
    1. Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512–527. - PMC - PubMed
    1. Irizarry M, van Dyck C, Li D, Dhadda S, Hersch S, Reyderman L, et al. The lecanemab clarity AD open-label extension in early Alzheimer’s disease (P1-3.003) Neurology. 2025;104(7 Suppl 1):4158
    1. Kang S, Yoon SH, Na HK, Lee YG, Jeon S, Baik K, et al. Neuropsychological comparison of patients with Alzheimer’s disease and dementia with Lewy bodies. J Clin Neurol. 2023;19:521–529. - PMC - PubMed
    1. Lee SM, Kwon KY. Comment on “neuropsychological comparison of patients with Alzheimer’s disease and dementia with Lewy bodies”. J Clin Neurol. 2023;19:514–515. - PMC - PubMed

Publication types

LinkOut - more resources